Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health...
Ginkgo Bioworks (NYSE:DNA - Get Free Report) released its earnings results on Thursday. The company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.24) by ($0.21). Ginkgo...
MarketBeat·19d ago
Ginkgo Bioworks (NYSE:DNA) Shares Gap Down After Earnings Miss
Ginkgo Bioworks (NYSE:DNA) Shares Gap Down on Disappointing Earnings...
MarketBeat·21d ago
Ginkgo Bioworks Holdings Q3 Loss Widens
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable...
Nasdaq News: Markets·22d ago
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire BOSTON, Nov. 6, 2025 Ginkgo provides an update on its third...
PR Newswire·22d ago
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership...
PR Newswire·29d ago
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire BOSTON, Oct. 30, 2025 Presentation and...
PR Newswire·29d ago
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.
Zacks·1mo ago
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program Ginkgo Bioworks in Partnership with STRM.BIO...
PR Newswire·1mo ago
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78, marking a -2.67% move from the previous day.